Vaccines (Oct 2021)

Hepatitis E Virus Quasispecies in Cerebrospinal Fluid with Neurological Manifestations

  • Florence Abravanel,
  • Florence Nicot,
  • Sébastien Lhomme,
  • Michele Cazabat,
  • Thomas Drumel,
  • Aurélie Velay,
  • Justine Latour,
  • Julie Belliere,
  • Pascal Cintas,
  • Nassim Kamar,
  • Jacques Izopet

DOI
https://doi.org/10.3390/vaccines9101205
Journal volume & issue
Vol. 9, no. 10
p. 1205

Abstract

Read online

Hepatitis E virus (HEV) infection can lead to a variety of neurological disorders. While HEV RNA is known to be present in the central nervous system, HEV quasispecies in serum and cerebrospinal fluid (CSF) have rarely been explored. We studied the virus’ quasispecies in the blood and the CSF of five patients at the onset of their neurological symptoms. The samples of three patients suffering from meningitis, neuralgic amyotrophy and acute inflammatory polyradiculoneuropathy were taken at the acute phase of the HEV infection. The samples from the other two patients were taken during the chronic phase (5 years after HEV diagnosis) when they presented with clinical signs of encephalitis. We sequenced at least 20 randomly polyproline regions of the selected virus clones. Phylogenetic analysis of the virus variants in the blood and the CSF revealed no virus compartmentalization for the three acute-phase patients but there was clear evidence of HEV quasispecies compartmentalization in the CSF of the two patients during chronic infection. In conclusion, prolonged infection in the immunocompromised condition can lead to independent virus replication in the liver and the tissues, producing viruses in CSF.

Keywords